S. South Korean drugmakers challenge Viagra in generics fight
News | 24 May 2012
South South Korean pharmaceutical firms are gearing up to enter the 100 billion won anti-impotence drug market as the main patent of the market leader, Pfizer's Viagra, expired last week, allowing for generic versions of the ?blue magic pill.
Click on the link to read the full article at Jakarta Post
(This link will open in a new window)
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
